Offer summary
Qualifications:
DVM with DACVP certification, 3+ years in toxicology pathology.Key responsabilities:
- Serve as Study Pathologist for GLP and non-GLP studies
- Collaborate with internal teams for histopathology best practices
The Director of Pathology will report to Head of Translational Biology and be based in Columbus, OH. He/She will primarily serve as Study Pathologist for GLP Toxicology studies and as a peer-reviewer for external toxicology studies. This Pathologist will collaborate closely with the Head of Non-Clinical Safety and associated study directors. This position will also serve as Study Pathologist for in-house non-GLP studies to support the research and development of Sarepta’s portfolio. Additionally, he/she will work closely with the necropsy, histology, and morphometrics teams in supporting best practices for histopathology and digital pathology; including review of new staining techniques and image analysis algorithms, support for validation activities of fit-for-purpose digital image analysis methods and provide expert quality review of clinical and non-clinical histopathology images.
Primary Responsibilities Include:
Collaborate with other scientists on R&D-wide initiatives and research projects
Desired Education and Skills:
#LI-TD1
#LI-OnsiteThis position requires work on site at one of Sarepta’s facilities in the United States.
The targeted salary range for this position is $171,200 - $214,000 per year. Sarepta is making a good faith effort to be transparent and accurate around our hiring ranges. The salary offer is commensurate with Sarepta’s compensation philosophy and considers factors including, but not limited to, education, training, experience, external market conditions, criticality of role, and internal equity.Candidates must be authorized to work in the U.S.
Sarepta Therapeutics offers a competitive compensation and benefit package.
Sarepta Therapeutics is an Equal Opportunity/Affirmative Action employer and participates in e-Verify.
Platina Recruitment Services
Boulevard
Centene Corporation